Placebo Surgery in Clinical Research Trials for Parkinson Disease

被引:0
作者
Dunlop, Susan Rebecca [1 ]
McCormick, Margaret [2 ]
机构
[1] Johns Hopkins Parkinsons Dis & Movement Disorders, Baltimore, MD 21287 USA
[2] Towson Univ, Towson, MD USA
来源
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2015年 / 11卷 / 02期
关键词
Belmont Report; Common Rule; deep brain stimulator; equipoise; ethics; fetal tissue transplantation; Parkinson disease; placebo surgery; SHAM SURGERY;
D O I
10.1016/j.nurpra.2014.07.022
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Advances in the field of neurology and neurosurgery have contributed to the development of novel approaches in the treatment of motor symptoms of Parkinson disease (PD). Comparative trials have been performed in PD to evaluate the efficacy of implanted fetal tissue against the standard of care and placebo surgery. Placebo surgery is when a research subject undergoes a surgical procedure that has the appearance of a therapeutic intervention but during which the essential therapeutic maneuver is omitted and is used as the control arm of the research trial. The purpose of this article is to allow nurse practitioners to review the use of placebo surgery as a control arm in the treatment of PD. The potential of transplantation surgeries to improve the lives of those living with neurodegenerative conditions is a fascinating and promising avenue of medical exploration. An overview of clinical trials in which placebo surgery is used as a control is discussed in this article along with the Common Rule and ethical principles to ensure the protection of human subjects in clinical research.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [41] Clinical Characteristics of Exacerbations in Parkinson Disease
    Zheng, Karen S.
    Dorfman, Benjamin J.
    Christos, Paul J.
    Khadem, Nasim R.
    Henchcliffe, Claire
    Piboolnurak, Panida
    Nirenberg, Melissa J.
    NEUROLOGIST, 2012, 18 (03) : 120 - 124
  • [42] The clinical diagnosis of Parkinson's disease
    Munhoz, Renato P.
    Tumas, Vitor
    Pedroso, Jose Luiz
    Silveira-Moriyama, Laura
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2024, 82 (06)
  • [43] Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research
    McMahon, Robert P.
    Kelly, Deanna L.
    Boggs, Douglas L.
    Li, Lan
    Hu, Qiaoyan
    Davis, John M.
    Carpenter, William T., Jr.
    SCHIZOPHRENIA BULLETIN, 2008, 34 (02) : 292 - 301
  • [44] The relevance of age and disease duration for intervention with subthalamic nucleus deep brain stimulation surgery in Parkinson disease Clinical article
    Parent, Brodie
    Awan, Nasir
    Berman, Sarah B.
    Suski, Valerie
    Moore, Robert
    Crammond, Donald
    Kondziolka, Douglas
    JOURNAL OF NEUROSURGERY, 2011, 114 (04) : 927 - 931
  • [45] RANDOMIZED CONTROLLED TRIALS OF MATERNAL-FETAL SURGERY: A CHALLENGE TO CLINICAL EQUIPOISE
    Rodrigues, H. C. M. L.
    van den Berg, P. P.
    BIOETHICS, 2014, 28 (08) : 405 - 413
  • [46] Ethical controversies on the use of placebo as control treatment in clinical trials in neurology
    Lahuerta, J.
    Gutierrez Rivas, E.
    Frias, J.
    Gracia, D.
    Dal-Re, R.
    NEUROLOGIA, 2007, 22 (02): : 106 - 113
  • [47] Reducing exposure of clinical research subjects to placebo treatments
    Noble, RES
    Gelfand, LA
    DeRubeis, RJ
    JOURNAL OF CLINICAL PSYCHOLOGY, 2005, 61 (07) : 881 - 892
  • [48] Not all placebos are the same: a debate on the ethics of placebo use in clinical trials versus clinical practice
    Alex Cahana
    Simone Romagnioli
    Journal of Anesthesia, 2007, 21 : 102 - 105
  • [49] Not all placebos are the same: a debate on the ethics of placebo use in clinical trials versus clinical practice
    Cahana, Alex
    Romagnioli, Simone
    JOURNAL OF ANESTHESIA, 2007, 21 (01) : 102 - 105
  • [50] Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management
    Soliman, Heithem
    Coffin, Benoit
    Gourcerol, Guillaume
    BRAIN SCIENCES, 2021, 11 (07)